A novel serum biomarker, clusterin, could be an early predictor of response to sorafenib
AASLD LiverLearning®, Takehisa Watanabe, 144139
Inhibition of sphingosine 1-phosphate signaling by FTY720 ameliorates murine nonalcoholic steatohepatitis
AASLD LiverLearning®, Amy Mauer, 144395
Geographic variation and provider characteristics affect receipt of curative therapy in early stage hepatocellular carcinoma: a Veteran cohort study.
AASLD LiverLearning®, Marina Serper, 144140
Mixed lineage kinase 3 mediates the induction of CXCL10 by a STAT1-dependent mechanism during hepatocyte lipotoxicity
AASLD LiverLearning®, Kyoko Tomita, 144396
ALBI and PALBI Grade Predict Survival for HCC across Treatment Modalities and BCLC Stages in the MELD Era
AASLD LiverLearning®, Po-Hong Liu, 144141
The Molecular Progression Of Nonalcoholic Fatty Liver Disease
AASLD LiverLearning®, Sophie Cazanave, 144397
Decision Making for Surveillance Interval: Who May Extend Intervals 1 Year After Curative Treatments for Hepatocellular Carcinoma
AASLD LiverLearning®, Minjong Lee, 144155
Second Harmonic Generation microscopy: a novel automated method for quantification of hepatic steatosis in chronic liver disease.
AASLD LiverLearning®, George Boon Bee Goh, 144411
A Novel Biomarker-Based Model for the Prediction of Response to Sorafenib and Overall Survival for Advanced Hepatocellular Carcinoma: A Prospective Cohort Study
AASLD LiverLearning®, Hwi Young Kim, 144156
CXCR3-/- mice are protected against nutrient excess diet-induced non-alcoholic steatohepatitis
AASLD LiverLearning®, Kyoko Tomita, 144412
Early decrease in alfafetoprotein as a prognosis factor of response in patients with advanced hepatocellular carcinoma treated with sorafenib
AASLD LiverLearning®, Teresa Ferrer Rios, 144157
Sevelamer hydrochloride treatment reverses steatohepatitis by attenuating mucosal inflammation and metabolic endotoxemia
AASLD LiverLearning®, Khalidur Rahman, 144413
Use of radiofrequency ablation and stereotactic body radiotherapy for the treatment of hepatocellular carcinoma: An analysis of the SEER-Medicare database
AASLD LiverLearning®, Neehar Parikh, 144171
SIRT3 Acts As a Negative Regulator of Autophagy Dictating Hepatocyte Susceptibility to Lipotoxicity
AASLD LiverLearning®, Zhenyuan Song, 144427
The Burden of Liver Cancer in the United States Population
AASLD LiverLearning®, Aynur Unalp-Arida, 144172
Modulation of HMGB1 - NF-κB translocation by curcumin treatment ameliorates liver injury in non-alcoholic steatohepatitis-hepatocellular carcinoma mouse model
AASLD LiverLearning®, MST. REJINA AFRIN, 144428
Vitamin K supplementation decreased the incidence of severe hand-foot skin reaction during sorafenib treatment for hepatocellular carcinoma.
AASLD LiverLearning®, Yoshimichi Haruna, 144173
Fully human 3D cell culture model of non-alcoholic steatohepatitis
AASLD LiverLearning®, Tomasz Kostrzewski, 144429
A cohort study of Hepatocellular Adenoma in post-menopausal women: can follow-up be safely terminated?
AASLD LiverLearning®, Anne Klompenhouwer, 144187
NOX1 Deletion Inhibits Hepatic Steatosis in db/db Model of Non-alcoholic Fatty Liver Disease
AASLD LiverLearning®, Sebastian Larion, 144443
Hepatocyte-derived osteopontin promotes the development of hepatocellular carcinoma
AASLD LiverLearning®, Chuck Blajszczak, 144188
Suppression of chromatin-remodeling component Arid1a contributes to NASH and hepatocellular carcinoma through transcriptional dysregulation of lipogenesis.
AASLD LiverLearning®, Jen-Chieh Chuang, 144444
Role of Aberrant NDRG3 Expression in Human Hepatocellular Carcinoma
AASLD LiverLearning®, Jin Jeong, 144189
Saturated Fat Causes Non-Alcoholic Steatohepatitis through the Shifting of the Gut Microbiota to a Higher Endotoxemic profile
AASLD LiverLearning®, S.M.Touhidul Islam, 144445
Portal Hypertension SIG: Hypercoagulability in Cirrhosis: Program Chair : Introductory Remarks
AASLD LiverLearning®, Cristina Ripoll, 154693
The Trend in Hepatitis Virus Treatment Status among Hepatocellular Carcinoma Patients with Chronic Viral Hepatitis Over the Last 15 Years
AASLD LiverLearning®, Ryosuke Tateishi, 144202
Phenotypical characterization of intrahepatic cholangiocarcinomas : the more fibrous, the less pejorative.
AASLD LiverLearning®, Lorraine Blaise, 144203
Role of 12-Lipoxygenase in a Zebrafish Model of Non Alcoholic Fatty Liver Disease (NAFLD)
AASLD LiverLearning®, Niharika Samala, 144459
SCCA-IgM helps to identify patients at risk of long-term hepatocelullar carcinoma
AASLD LiverLearning®, Javier Ampuero, 144204
Targeting Mitochondrial Pyruvate Metabolism to Ameliorate Hepatic Fibrosis in a Mouse Model of NASH
AASLD LiverLearning®, Brian Finck, 144460
Comparison of Staging Systems for Hepatocellular Carcinoma in a Multicenter US Cohort
AASLD LiverLearning®, Neehar Parikh, 144205
EDP-305, A Novel and Highly Potent Farnesoid X Receptor Agonist, Exerts Favorable Effects on Lipid Metabolism In Vitro
AASLD LiverLearning®, Lijuan Jiang, 144461
RNA interference (RNAi) with ARC-AAT provides deep and prolonged knockdown of alpha-1 antitrypsin levels in healthy volunteers
AASLD LiverLearning®, James Hamilton, 154964
Kwashiorkor Malnutrition is Marked by Reduced Serum Concentrations of Essential Amino Acids
AASLD LiverLearning®, Thaddaeus May, 154965
Addition of simvastatin to carvedilol does not improve hemodynamic response in cirrhotics with varices without prior bleed: Preliminary results of an open label RCT
AASLD LiverLearning®, Arvind Rangarajan-Murali, 154966
Unusually High HCC Rates Among Patients With HCV Cirrhosis After Treatment With Direct Acting Antivirals
AASLD LiverLearning®, Sudha Kodali, 144218
High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
AASLD LiverLearning®, Helder Cardoso, 144219
APRI as a Tool to Initiate Increased Surveillance for HCC in African Americans
AASLD LiverLearning®, Paul Naylor, 144220
Pathophysiologic model of non-alcoholic fatty liver disease using precision-cut liver slices
AASLD LiverLearning®, Theerut Luangmonkong, 144476
Surveillance for Hepatobiliary Cancer in Primary Sclerosing Cholangitis
AASLD LiverLearning®, Navine Nasser-Ghodsi, 144221
A diet enriched in starch and oleate induces activation of NK cells and causes exaggerated suppression of de novo lipogenesis in adipose tissue, resulting in hepatic steatosis.
AASLD LiverLearning®, Caroline Duwaerts, 144477
MEDI0382, a dual GLP-1/glucagon receptor agonist, exerts beneficial effects on mitochondrial content and function in primary hepatocytes from lean and NASH mice
AASLD LiverLearning®, Michelle Beaton, 144478
The features of hepatocellular carcinoma after IFN free treatment
AASLD LiverLearning®, Masataka Seike, 144234
Hepatitis B and C as Risk Factors for Early Hepatocellular Carcinoma Across South America
AASLD LiverLearning®, Jose Debes, 144235
MELD score higher than 14 is the safety cutoff for patients with Child Pugh B or C cirrhosis undergoing drug-eluting beads chemoembolization for hepatocellular carcinoma.
AASLD LiverLearning®, castel helene, 144236
GPR91 antagonism: A novel approach for the treatment of nonalcoholic steatohepatitis (NASH)
AASLD LiverLearning®, Dhananjay Umrani, 144492
Is percutaneous approach better than endoscopic approach for successful biliary drainage in palliation of unresectable hilar cholangiocarcinoma: A meta-analysis and systematic review.
AASLD LiverLearning®, Abhiram Duvvuri, 144237
TRPV4 prevents tissue injury in diseased fatty liver by blocking CYP2E1-mediated redox-toxicity via Kupffer cell-induced nitric oxide production
AASLD LiverLearning®, Ratanesh Seth, 144493
Hepatocellular Nuclear Factor 4α (HNF-4α) activation by saRNA rescues dyslipidemia and promotes favorable metabolic profile in a high fat diet (HFD) fed rat model.
AASLD LiverLearning®, Vikash Reebye, 144494
Rising Inpatient Healthcare Resource Utilization in Baby Boomers with Hepatocellular Carcinoma
AASLD LiverLearning®, George Cholankeril, 144250
Hepatocellular Carcinoma is Independently Associated with Increased Mortality in Patients with Cirrhosis Admitted to Intensive Care Units
AASLD LiverLearning®, Christina Lindenmeyer, 144251
Outcomes of a new very small diameter drug eluting embolic beads for transarterial chemoembolization in unresectable hepatocellular carcinoma.
AASLD LiverLearning®, Mohamed Shoreibah, 144252
Poor Glycemic Control in Patients with Diabetes Increases the Risk of Hepatocellular Carcinoma
AASLD LiverLearning®, Jeffrey Nadelson, 144253
Febuxostat prevents diet-induced steatohepatitis and insulin resistance in mice: A comparison with allopurinol
AASLD LiverLearning®, Tomoki Nishikawa, 144509
Interleukin-33 influence the progression of NASH by acting on monocytes
AASLD LiverLearning®, Jingmin Zhao, 144510
Saroglitazar attenuates hepatic inflammation, oxidative stress and fibrosis in models of NAFLD/NASH
AASLD LiverLearning®, Mukul Jain, 144511
Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation
AASLD LiverLearning®, murat dayangac, 144266
Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States- a 4.5 Year Single-Center Experience
AASLD LiverLearning®, Gene Im, 144267
Factors Predicting Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Post-transplant Pathologic Stage
AASLD LiverLearning®, Brett Ecker, 144268
Factors Associated with Misdiagnosis of Hepatocellular Carcinoma before Liver Transplant with No Tumors Found on Explant: An Analysis of the UNOS database
AASLD LiverLearning®, Neil Mehta, 144269
Daclatasvir in combination with other DAAs achieves high rate of virological clearance with excellent safety profile in liver tranplanted patients for hepatitis C
AASLD LiverLearning®, Raffaella Lionetti, 144525
Variation in Demographics and Comorbidities in HCV Liver Transplant Recipients within UNOS Regions
AASLD LiverLearning®, George Cholankeril, 144526
100% Virological response with 3D regimen and significant short-term liver stiffness improvement in patients with recurrent hepatitis C following liver transplantation
AASLD LiverLearning®, Maria C. Speranta Iacob, 144527
Donor Diabetes Mellitus And Prolonged Cold Ischemia have a Synergistic Effect on Graft Failure After Liver Transplantation
AASLD LiverLearning®, Paulo N Martins, 144282
Kinetic AFP model analysis in patients awaiting liver transplantation (LT) for hepatocellular carcinoma (HCC): a risk factor for microvascular invasion and recurrence
AASLD LiverLearning®, Lucile Boivineau, 144283
Similar Donor and Recipient Outcomes After Left Lobe and Right Lobe Living Donor Liver Transplantation
AASLD LiverLearning®, Tiffany Wong, 144284
Hepatic venous outflow obstruction in polycystic liver disease: impact on pathology and intra and postoperative course after liver resection
AASLD LiverLearning®, Louise Barbier, 144285
Hepatocellular Carcinoma is the Leading Indication in Liver Transplant Registrants and Recipients in the United States
AASLD LiverLearning®, Ju Dong Yang, 144298
Evaluating Liver Biopsy Predictors for Outcomes in Transplant Recipients with Cardiac/ Liver Disease
AASLD LiverLearning®, Tatyana Kushner, 144299
2-dimensional shear wave elastography rather than HVPG significantly improves MELD-Na to predict survival in decompensated cirrhosis patients
AASLD LiverLearning®, Maja Thiele, 144300
Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure (ACLF) with Hepatic Encephalopathy (HE): A Randomized Trial (ClinicalTrials.gov Identifier: NCT02321371)
AASLD LiverLearning®, Anand Kulkarni, 144301
Comparative effectiveness of different pharmacological interventions for the treatment of minimal hepatic encephalopathy: A Systematic review with network meta-analysis
AASLD LiverLearning®, Radha Dhiman, 144314
Prevalence and Correlation of Diabetes with Severity of Chronic Liver Disease and Utility of HBA1C in these Patients as Compared with Oral Glucose Tolerance Test
AASLD LiverLearning®, Tejasav Sehrawat, 144315
Hepatocellular Carcinoma amongst Cirrhosis: Trends in Hospitalization and Inpatient Mortality in United States
AASLD LiverLearning®, Kalpit Devani, 144316
Early impaired neurological functioning after TIPS placement: a multimodal MRI studies
AASLD LiverLearning®, Marika Rudler, 144317
Long term follow-up progresses of patients after autologous bone marrow cell infusion for decompensated liver cirrhosis
AASLD LiverLearning®, Kwan Sik Lee, 144330
Palliative Care Utilization is Associated with Reduced Costs and Reduced Procedures in the Setting of Hepatocellular Carcinoma with Mortality: A Study of the National Inpatient Sample
AASLD LiverLearning®, Anne Liu, 144331
Prevalence, Predictors And Outcomes Of Hypoxic Hepatitis In Critically Ill Cirrhotics-A Single Center Prospective Study
AASLD LiverLearning®, RAKHI MAIWALL, 144332
Genomic Characterization of Stool Microbiota With Rifaximin Monotherapy Versus Lactulose Combination Therapy for Prevention of Overt Hepatic Encephalopathy (HE) Recurrence
AASLD LiverLearning®, Herbert DuPont, 144333
Safety, Tolerability, Pharmacokinetics (PK) and Antiviral Activity of EDP-494, a Potent Pan-Genotypic Cyclophilin (Cyp) Inhibitor for Chronic Hepatitis C Infection (CHC), in Healthy Subjects (HS) and in CHC Genotype 1 and 3 Patients: Preliminary Result
AASLD LiverLearning®, Edward Gane, 144346
FOXO3-dependent, M1-selective hepatic macrophage apoptosis is a normal mechanism that allows the liver to tolerate alcohol with minimal or no inflammation
AASLD LiverLearning®, Zhuan Li, 144091
Triple Combination Drug Interaction Studies of the Nucleotide Analog, AL-335, in Combination with Simeprevir and Odalasvir Demonstrate Significant Synergy in the Hepatitis C Virus (HCV) Subgenomic Replicon System
AASLD LiverLearning®, Hua Tan, 144347
Restoration of bile acid homeostasis improves alcoholic liver disease in mice
AASLD LiverLearning®, Phillipp Hartmann, 144092
Towards a Single Treatment Cure for HCV: Reformulation of the Pan-genotypic NNI GSK2878175 as a Long Acting Parenteral (LAP) and In Vivo Proof of Concept
AASLD LiverLearning®, Martin Leivers, 144348
Osteopontin ablation drives hematopoietic stem cell mobilization and increases hepatic iron contributing to alcoholic liver disease
AASLD LiverLearning®, Fernando Magdaleno Verduzco, 144093
Pharmacokinetics (PK), safety and tolerability of the 2- and 3-direct acting antiviral (DAA) combination of AL-335, odalasvir (ODV) and simeprevir (SMV) administered once-daily (QD) in healthy volunteers (HVs)
AASLD LiverLearning®, Thomas Kakuda, 144349
MicroRNA-130a regulates HCV and HBV replication through a central metabolic pathway
AASLD LiverLearning®, Xiaoqiong Duan, 144362
The Role of Protein Carbonylation in Progression of Alcoholic Liver Disease in Male GSTA4-4 -/- Mice
AASLD LiverLearning®, Colin Shearn, 144107
Elevated plasma miR-24, miR-223, and PCSK9 levels in hepatitis C-infected patients who achieve a treatment-based viral cure
AASLD LiverLearning®, Anastasia Hyrina, 144363
PNPLA3 G/G genotype doubles the mortality risk of patients with portal hypertension due to fatty liver disease
AASLD LiverLearning®, Mattias Mandorfer, 144108
Patients failing all-oral interferon-free DAA regimens in Spain. Virological characterization of the HCVREsp cohort.
Hepatic Cell Death Caused by Fungi as well as Bacteria Is Mediated by ROS Induction of Nuclear Transglutaminase in Hepatic Cells
AASLD LiverLearning®, Soichi Kojima, 144109
Intrahepatic Th17/Treg interplay related to fibrosis in Chronic Hepatitis C
AASLD LiverLearning®, Daniela Rios, 144365
IL-22 mediates liver fibrosis in patients with chronic hepatitis C by inducing IL-20 production
AASLD LiverLearning®, Jingmin Zhao, 144378
Acute Alcoholic Hepatitis has Comparable Survival following Liver Transplantation to Other Causes of Acute Liver Failure
AASLD LiverLearning®, George Cholankeril, 144123
Enhanced Natural Killer Cell Activity and Natural Resistance to Viral Infection amongst Irish Women Exposed to Hepatitis C Virus via Contaminated Anti-D Immunoglobulin
AASLD LiverLearning®, Mark Robinson, 144379
Excess Adiposity in Alcoholic Hepatitis Increases Mortality and Morbidity
AASLD LiverLearning®, Richard Parker, 144124
Immune regulation via the gut-liver axis plays a pivotal role in the pathogenesis of alcohol-induced liver disease
AASLD LiverLearning®, Shunsuke Shiba, 144125
Carcinoembryonic-antigen-related cell-adhesion molecule 1 is associated with the suppression of NK cells function in chronic hepatitis C.
AASLD LiverLearning®, Takahiro Suda, 144381
HCV Infection Induces Caspase Activation and Regulation of Telomerase Expression.
AASLD LiverLearning®, Huy TRAN, 144382